Trademarkia Logo

Canada

C$
ACCUM-002
OPPOSED

Last Applicant/ Owned by

DEFENCE THERAPEUTICS INC.

200 Burrard Street, Suite 1680Vancouver

BRITISH COLUMBIA

CA

V6C3L6

Serial Number

2277591 filed on 25th Aug 2023

Correspondent Address

MCMILLAN LLP

BROOKFIELD PLACE, SUITE 4400BAY WELLINGTON TOWER181 BAY STREETTORONTO

ONTARIO

CA

M5J2T3

ACCUM-002

Trademark usage description

drug delivery agent in the form of an intracellular enhancer; medicinal preparations for use in oncology; pharmaceutical antibody preparations for the Read More

Classification Information


Class [005]
Drug delivery agent in the form of an intracellular enhancer; medicinal preparations for use in oncology; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; vaccines for human use


Classification kind code

12

Class [042]
Antibody profiling for scientific research purposes; research and development of vaccines and medicines; scientific research for medical purposes in the field of oncology


Classification kind code

12

Mark Details


Serial Number

2277591

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 110
on 14th Mar 2025
Proposed Opposition
Submitted for opposition 48
on 14th Mar 2025
Agent Changed
Submitted for opposition 42
on 15th Jan 2025
Advertised
Submitted for opposition 26
on 19th Dec 2024
Approved
Submitted for opposition 27
on 19th Dec 2024
Approval Notice Sent
Submitted for opposition 22
on 11th Dec 2024
Search Recorded
Submitted for opposition 30
on 25th Aug 2023
Filed
Submitted for opposition 1
on 25th Aug 2023
Created
Submitted for opposition 31
on 25th Aug 2023
Formalized